Marker Therapeutics (MRKR) Other Non-Current Assets (2010 - 2022)
Marker Therapeutics (MRKR) posted quarterly Other Non-Current Assets of $17.8 million for Q4 2022, up 1518.45% year-over-year from $1.1 million in Q4 2021, and up 8801.46% quarter-over-quarter from $200000.0 in Q1 2022.
Marker Therapeutics (MRKR) Other Non-Current Assets (2010 - 2022) Analysis & Trends
Marker Therapeutics (MRKR) has reported Other Non-Current Assets for 8 consecutive years, with $17.8 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Other Non-Current Assets rose 1518.45% year-over-year to $17.8 million; the TTM figure through Dec 2022 stood at $17.8 million (up 1518.45% YoY), while the FY2022 annual figure was $17.8 million, up 1518.45% from the prior year.
- Other Non-Current Assets improved to $17.8 million in Q4 2022 per MRKR's latest filing, from $200000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $17.8 million in Q4 2022 and bottomed at $200000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 17.80 Mn |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Dec 31, 2015 | 68,803.00 |
| Sep 30, 2015 | 138,286.00 |
| Jun 30, 2015 | 142,590.00 |
| Mar 31, 2015 | 82,504.00 |
| Dec 31, 2014 | 82,504.00 |
| Mar 31, 2014 | 747.00 |
| Dec 31, 2013 | 13,439.00 |
| Sep 30, 2013 | 118,954.00 |
| Mar 31, 2013 | 20,145.00 |
| Dec 31, 2012 | 37,452.00 |
| Sep 30, 2012 | 12,641.00 |
| Jun 30, 2012 | 24,637.00 |
| Mar 31, 2012 | 28,464.00 |
| Dec 31, 2011 | 32,291.00 |
| Sep 30, 2011 | 36,160.00 |
| Jun 30, 2011 | 40,029.00 |
| Dec 31, 2010 | 91,134.00 |